Profile
AVR ABT BSX-PA BSX SYK MDT
Company Name Anteris Technologies Global Corp. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $147.86M $230.05B $175.45B $159.33B $148.97B $118.20B
Employees 0.14K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Wayne Geoffrey Paterson Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
AVR ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
AVR ABT BSX-PA BSX SYK MDT
Last Close $4.1 $132.18 $122.18 $107.53 $388.56 $92.25
High 52 $8.78 $140.22 $122.18 $107.76 $403.53 $94.5
Low 52 $2.47 $111.1 $122.18 $81.37 $337.28 $79.61
Price vs. 52 Week High -53.3 % -5.73 % 0 % -0.21 % -3.71 % -2.38 %
Price vs. 52 Week Low 65.99 % 18.97 % 0 % 32.15 % 15.2 % 15.88 %
Total Return
AVR ABT BSX-PA BSX SYK MDT
1 Month Return 19.53 % 1.73 % 0 % 0.69 % 1.85 % 2.91 %
3 Month Return -13.68 % -0.59 % 0 % 4.98 % 1.56 % 7.77 %
6 Month Return -44.74 % -3.92 % 0 % 3.78 % -0.35 % -0.84 %
9 Month Return 0 % 13.98 % 0 % 18.37 % -0.31 % 8.12 %
YTD Return -26.52 % 16.86 % 0 % 20.39 % 7.92 % 15.49 %
1 Year Return 0 % 15.54 % 0 % 31.2 % 7.84 % 1.34 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVR ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.76 % - - 0.85 % 3.05 %
Dividend Paid and Capex Coverage Ration (TTM) -63.02 % 1.45 % 3.96 % 3.96 % 2.2 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - - 3.32 % 2.81 %
Payout Ratio (TTM) - 28.42 % 0.92 % 0.92 % 42.32 % 77.26 %
Growth
AVR ABT BSX-PA BSX SYK MDT
Asset Growth 164.35 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth 44.39 % 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth -1.16 % 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year -17.73 % -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year -12.11 % 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year -12.11 % 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth -67.83 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth -65.77 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share -688.43 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share -1049.56 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share -1049.56 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth -62.8 % 6.46 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) -76.84 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG -652.69 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG -880.66 % 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG -880.66 % 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth -194.53 % 134.55 % 16.55 % 16.55 % 31.05 %
EPS Diluted Growth -194.53 % 133.64 % 16.25 % 16.25 % 30.8 %
Book Value Per Share 488.59 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share 958.18 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 5900.72 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 5900.72 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth -12.58 % -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth -71.52 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
AVR ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 59.41 % 52.92 % 63.23 % 63.23 % 62.19 % 63.44 %
Return on Assets TTM -211.21 % 16.64 % 6.23 % 6.23 % 6.3 % 5.12 %
Return on Equity TTM -252.22 % 29.93 % 11.77 % 11.77 % 14.08 % 9.62 %
Return on Capital Employed TTM -160.93 % 10.76 % 8.84 % 8.84 % 13.86 % 7.71 %
Net Income Per EBT TTM 100.28 % 176.99 % 83.43 % 83.43 % 87.08 % 82.32 %
EBT Per Ebit TTM 196.65 % 103.99 % 96.68 % 96.68 % 61.93 % 92.49 %
EBIT Per Revenue TTM -1722.81 % 17.62 % 16.77 % 16.77 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM -2612.61 % 67.25 % 32.56 % 32.56 % 25.04 % 24.98 %
Receivables Turnover TTM 3.61 4.21 6.87 6.87 6.08 5.46
Payables Turnover TTM 0.19 4.71 6.77 6.77 6.25 4.89
Inventory Turnover TTM 2.24 2.92 2.37 2.37 1.7 -33.52
Fixed Asset Turnover TTM 35.14 % 378.32 % 481.99 % 481.99 % 560.03 % -6785.71 %
Asset Turnover TTM 6.22 % 51.32 % 46.07 % 46.07 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -3.11 5.19 2.58 2.58 11.22 5.58
Free Cash Flow Per Share TTM -3.16 3.89 1.94 1.94 9.36 4.14
Cash Per Share TTM 120.62 % 418.4 % 49.04 % 49.04 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -2959.23 % 20.96 % 20.61 % 20.61 % 18 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.59 % 74.97 % 75.37 % 75.37 % 83.42 % 74.21 %
Cash Flow Coverage Ratios TTM -2612.61 % 67.25 % 32.56 % 32.56 % 25.04 % 24.98 %
Price To Free Cash Flows Ratio TTM -1.29 33.96 54.76 55.46 41.65 22.29
Price To Operating Cash Flows Ratio TTM -0.86 25.46 41.18 41.71 34.73 16.54
Price Cash Flow Ratio TTM -0.86 25.46 41.18 41.71 34.73 16.54
Income Statement (TTM)
AVR ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio 46.84% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $-0.08B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.08B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -3.77 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
AVR ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0.02B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.06B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0.08B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
AVR ABT BSX-PA BSX SYK MDT
Net Income $-0.08B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $-0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.06B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 132.18
ADGM Adagio Medical Holdings, Inc. 1.635
AEMD Aethlon Medical, Inc. 1.35
AFIB Acutus Medical, Inc. 0.0006
AHCO AdaptHealth Corp. 9.09
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 132.355
ALUR Allurion Technologies Inc. 2.12
AMIX Autonomix Medical, Inc. Common Stock 1.18
ANIK Anika Therapeutics, Inc. 9.01
AORT Artivion, Inc. 43.32
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.9
ARAY Accuray Incorporated 1.46
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.9
AVNS Avanos Medical, Inc. 12.35
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 15.61
ETFs With Exposure to AVR
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00257 233.67
IWN iShares Russell 2000 Value ETF 0.00294 173.01
IWO iShares Russell 2000 Growth ETF 0.00603 305.54
VXF Vanguard Extended Market Index Fund 0.00069 204.32
HDG ProShares Hedge Replication ETF 0.00044261 50.6
UWM ProShares Ultra Russell2000 0.00240465 43.45
IWC iShares Micro-Cap ETF 0.02184 141.58
URTY ProShares UltraPro Russell2000 0.00191102 48.13
VTWV Vanguard Russell 2000 Value Index Fund 0.0033 152.48
VTWG Vanguard Russell 2000 Growth Index Fund 0.00508 223.01
VTWO Vanguard Russell 2000 Index Fund 0.00259 94.53
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 44.57
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00069 155.01
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00069 155.02
VEMPX Vanguard Extended Market Index InstlPlus 0.00069 382.55
RSSL Global X Funds 0 91.72
Unlock